134 related articles for article (PubMed ID: 12730682)
1. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells.
Mackay A; Jones C; Dexter T; Silva RL; Bulmer K; Jones A; Simpson P; Harris RA; Jat PS; Neville AM; Reis LF; Lakhani SR; O'Hare MJ
Oncogene; 2003 May; 22(17):2680-8. PubMed ID: 12730682
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome characterization of human mammary cell lines expressing different levels of ERBB2 by serial analysis of gene expression.
dos Santos ML; Palanch CG; Salaorni S; Da Silva WA; Nagai MA
Int J Oncol; 2006 Jun; 28(6):1441-61. PubMed ID: 16685446
[TBL] [Abstract][Full Text] [Related]
3. Gene expression analysis in SV40-immortalized human breast luminal epithelial cells with stem cell characteristics using a cDNA microarray.
Park JS; Noh DY; Kim SH; Kim SH; Kong G; Chang CC; Lee YS; Trosko JE; Kang KS
Int J Oncol; 2004 Jun; 24(6):1545-58. PubMed ID: 15138599
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
Ma C; Lin H; Leonard SS; Shi X; Ye J; Luo J
Oncogene; 2003 Aug; 22(34):5281-90. PubMed ID: 12917629
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
6. Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line CAL51.
Klebig C; Seitz S; Korsching E; Kristiansen G; Gustavus D; Scherneck S; Petersen I
Genes Chromosomes Cancer; 2005 Nov; 44(3):233-46. PubMed ID: 16049915
[TBL] [Abstract][Full Text] [Related]
7. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes.
Mazurek N; Sun YJ; Price JE; Ramdas L; Schober W; Nangia-Makker P; Byrd JC; Raz A; Bresalier RS
Cancer Res; 2005 Dec; 65(23):10767-75. PubMed ID: 16322222
[TBL] [Abstract][Full Text] [Related]
10. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of ErbB receptor and ligand-dependent transcription.
Amin DN; Perkins AS; Stern DF
Oncogene; 2004 Feb; 23(7):1428-38. PubMed ID: 14973552
[TBL] [Abstract][Full Text] [Related]
12. Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.
D'Souza B; Berdichevsky F; Kyprianou N; Taylor-Papadimitriou J
Oncogene; 1993 Jul; 8(7):1797-806. PubMed ID: 8099725
[TBL] [Abstract][Full Text] [Related]
13. ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer.
Petry IB; Fieber E; Schmidt M; Gehrmann M; Gebhard S; Hermes M; Schormann W; Selinski S; Freis E; Schwender H; Brulport M; Ickstadt K; Rahnenführer J; Maccoux L; West J; Kölbl H; Schuler M; Hengstler JG
Clin Cancer Res; 2010 Jan; 16(2):451-60. PubMed ID: 20068093
[TBL] [Abstract][Full Text] [Related]
14. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.
Worthington J; Bertani M; Chan HL; Gerrits B; Timms JF
BMC Cancer; 2010 Sep; 10():490. PubMed ID: 20840765
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.
Dressman MA; Baras A; Malinowski R; Alvis LB; Kwon I; Walz TM; Polymeropoulos MH
Cancer Res; 2003 May; 63(9):2194-9. PubMed ID: 12727839
[TBL] [Abstract][Full Text] [Related]
17. In silico identification of breast cancer genes by combined multiple high throughput analyses.
Shen D; He J; Chang HR
Int J Mol Med; 2005 Feb; 15(2):205-12. PubMed ID: 15647832
[TBL] [Abstract][Full Text] [Related]
18. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
19. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Mamessier E; Adélaïde J; Debono S; Houvenaeghel G; Maraninchi D; Viens P; Charpin C; Jacquemier J; Birnbaum D
Cancer Res; 2006 May; 66(9):4636-44. PubMed ID: 16651414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]